(Total Views: 367)
Posted On: 07/22/2019 5:36:45 PM
Post# of 154029
I agree that leronlimab is far superior. Just stating that competition will continue and we will not own the HIV market overnight......it will take time even when facing inferior products. Even 5% of US market will be significant revenue and share price appreciation.
(1)
(0)
Please do your own due diligence. All my posts and comments are not to be considered investment advice.
